Format

Send to:

Choose Destination
See comment in PubMed Commons below
Pharmacogenomics. 2012 Jan;13(2):213-22. doi: 10.2217/pgs.11.145.

Integrating heterogeneous high-throughput data for meta-dimensional pharmacogenomics and disease-related studies.

Author information

  • 1Center for Human Genetics Research, Vanderbilt University, Department of Molecular Physiology & Biophysics, Nashville, TN, USA.

Abstract

The current paradigm of human genetics research is to analyze variation of a single data type (i.e., DNA sequence or RNA levels) to detect genes and pathways that underlie complex traits such as disease state or drug response. While these studies have detected thousands of variations that associate with hundreds of complex phenotypes, much of the estimated heritability, or trait variability due to genetic factors, remain unexplained. We may be able to account for a portion of the missing heritability if we incorporate a systems biology approach into these analyses. Rapid technological advances will make it possible for scientists to explore this hypothesis via the generation of high-throughput omics data - transcriptomic, proteomic and methylomic to name a few. Analyzing this 'meta-dimensional' data will require clever statistical techniques that allow for the integration of qualitative and quantitative predictor variables. For this article, we examine two major categories of approaches for integrated data analysis, give examples of their use in experimental and in silico datasets, and assess the limitations of each method.

PMID:
22256870
[PubMed - indexed for MEDLINE]
PMCID:
PMC3350322
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon Icon for PubMed Central
    Loading ...
    Write to the Help Desk